Neovasc regains Nasdaq listing compliance
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Neovasc Inc. is no longer in violation of Nasdaq's listing requirements.
The specialty cardiovascular medical device company regained compliance after its stock price hovered above $1 for 10 consecutive days.
